Academic Bibliography

Search 200 years of publications by Ghent University researchers.

prof. Yolande Lievens

Work address: C. Heymanslaan 10
9000 Gent
Email: YOLANDE.LIEVENS@UGent.be

Show Sort by

Mark
- journalArticle
- A1
- open access
Radiation therapy research : a global analysis 2001-2015

Ajay Aggarwal, Grant Lewison, Danielle Rodin, Anthony Zietman, Richard Sullivan and Yolande Lievens (UGent)

(2018) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 101(4). p.767-778
Mark
Radiation therapy quality assurance (RTQA) of concurrent chemoradiation therapy for locally advanced non-small cell lung cancer in the PROCLAIM Phase 3 trial

Anthony M Brade, Frederik Wenz, Friederike Koppe, Yolande Lievens (UGent) , Belen San Antonio, Neill A Iscoe, Anwar Hossain, Nadia Chouaki and Suresh Senan

(2018) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 101(4). p.927-934
Mark
- misc
Doing the right thing : quality in radiotherapy, a European perspective

A Vaandering, N Jornet, P Scalliet, M Coffey and Yolande Lievens (UGent)

(2018) RADIOTHERAPY AND ONCOLOGY. 127(2). p.161-163
Mark
Inter-observer variation of hippocampus delineation in hippocampal avoidance prophylactic cranial irradiation

F Bartel, M van Herk, H Vrenken, F Vandaele, S Sunaert, K de Jaeger, NJ Dollekamp, C Carbaat, E Lamers, EMT Dieleman, et al.

(2018) CLINICAL & TRANSLATIONAL ONCOLOGY.
Mark
Economic data for particle therapy : dealing with different needs in a heterogeneous landscape

Yolande Lievens (UGent) and Klaus Nagels

(2018) RADIOTHERAPY AND ONCOLOGY. 128(1). p.19-25
Mark
ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer

Ursula Nestle, Dirk De Ruysscher, Umberto Ricardi, Xavier Geets, Jose Belderbos, Christoph Poettgen, Rafal Dziadiuszko, Stephanie Peeters, Yolande Lievens (UGent) , Coen Hurkmans, et al.

(2018) RADIOTHERAPY AND ONCOLOGY. 127(1). p.1-5
Mark
External partial breast irradiation in prone position : how to improve accuracy?

Christel Monten (UGent) , Liv Veldeman (UGent) , Katrien Vandecasteele (UGent) , Ana Maria Luiza Olteanu (UGent) , Werner De Gersem (UGent) , Tom Vercauteren (UGent) , THOMAS MULLIEZ, Rudy Van den Broecke (UGent) , Herman Depypere (UGent) , Wilfried De Neve (UGent) , et al.

(2018) ACTA ONCOLOGICA.
Mark
Estimating the number of fractions by tumour site for European countries in 2012 and 2025 : an ESTRO-HERO analysis

Josep M Borras, Cai Grau, Julieta Corral, Karen Wong, Michael B Barton, Jacques Ferlay, Freddie Bray and Yolande Lievens (UGent)

(2018) RADIOTHERAPY AND ONCOLOGY. 126(2). p.198-204
Mark
Adjuvant breast radiotherapy : how to trade-off cost and effectiveness?

Christel Monten (UGent) and Yolande Lievens (UGent)

(2018) RADIOTHERAPY AND ONCOLOGY. 126(1). p.132-138
Mark
Interobserver delineation uncertainty in involved-node radiation therapy (INRT) for early-stage Hodgkin lymphoma : on behalf of the Radiotherapy Committee of the EORTC lymphoma group

Marianne C Aznar, Theodore Girinsky, Anne Kiil Berthelsen, Berthe Aleman, Max Beijert, Martin Hutchings, Yolande Lievens (UGent) , Paul Meijnders, Peter Meidahl Petersen, Deborah Schut, et al.

(2017) ACTA ONCOLOGICA. 56(4). p.608-613

1
2
3
4
…
10
11

Next →